This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Hamid Trimech
Business Development Manager at Arcalis
Speaker

Profile

Hamid is a process engineer, passionate about vaccine manufacturing with broad experience in manufacturing of multiple vaccine modalities including attenuated vaccines, inactivated vaccines, subunit vaccines, recombinant protein vaccines, conjugated vaccines, and most recently, mRNA vaccines.

Currently based in Japan, Hamid oversees the global business development activities of ARCALIS Inc., a Japanese CDMO specializing on mRNA vaccines and therapeutics.

Prior to his business development role, Hamid was the lead engineer for the construction of ARCALIS Drug substance manufacturing site in Fukushima Prefecture and played a crucial role in the technology transfer of a Self-amplifying mRNA vaccine from the United States to Japan.

Prior joining ARCALIS Inc., Hamid worked in Lyon, France, as process engineer at Sanofi Pasteur global engineering department and managed vaccine drug substance manufacturing facility construction projects in South America and Asia.

Agenda Sessions

  • A Strategy to Develop Potential and Safe mRNA-based Therapeutics

    3:50pm